Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Brimonidine eye drops in acute ischemic optic neuropathy
NL-OMON22790Active, not recruiting
- Start
- Feb 2001
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of brimonidine in anterior ischemic optic neuropathy (AION). Primary endpoint: Thickness of peripapillary nerve fiber layer. Started Feb 2001; status: active, not recruiting.
02
Drugs
brimonidine
03
Conditions
anterior ischemic optic neuropathy (AION)
Beyond the preview
Go deeper on NL-OMON22790.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON22790.